InVivo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NVIV and buy or sell other stocks, ETFs, and their options commission-free!About NVIV
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.
CEORichard Toselli, MD, MBA
CEORichard Toselli, MD, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2005
Founded2005
Employees—
Employees—
NVIV Key Statistics
Market cap1.15M
Market cap1.15M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume11.58K
Average volume11.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.4348
52 Week high$0.4348
52 Week low$0.15
52 Week low$0.15
People also own
Based on the portfolios of people who own NVIV. This list is generated using Robinhood data, and it’s not a recommendation.